SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001213900-21-045064
Filing Date
2021-08-26
Accepted
2021-08-26 16:42:38
Documents
36
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM ea146420-6ka1_scis.htm   iXBRL 6-K/A 17132
2 SCISPARC LTD.'S UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF JUNE 3 ea146420ex99-1_scisparcltd.htm   iXBRL EX-99.1 CHARTER 393630
  Complete submission text file 0001213900-21-045064.txt   2010532

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sprcy-20210630.xsd EX-101.SCH 34562
4 XBRL CALCULATION FILE sprcy-20210630_cal.xml EX-101.CAL 25904
5 XBRL DEFINITION FILE sprcy-20210630_def.xml EX-101.DEF 102233
6 XBRL LABEL FILE sprcy-20210630_lab.xml EX-101.LAB 219531
7 XBRL PRESENTATION FILE sprcy-20210630_pre.xml EX-101.PRE 107394
8 EXTRACTED XBRL INSTANCE DOCUMENT ea146420-6ka1_scis_htm.xml XML 224754
Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd./ADR (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-38041 | Film No.: 211212965
SIC: 2834 Pharmaceutical Preparations